Dianthus Therapeutics, Inc. (NASDAQ: DNTH) reported Q3 EPS of ($3.78), $3.49 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Dianthus Therapeutics, Inc. (DNTH) click here.